Tech Company Financing Transactions
Anthera Pharmaceuticals Funding Round
On 11/13/2017, Anthera Pharmaceuticals secured $2.9 million in funding from private investors.
Transaction Overview
Company Name
Announced On
11/13/2017
Transaction Type
Venture Equity
Amount
$2,883,421
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 21 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
700 Milam 1300
Houston, TX 77002
USA
Houston, TX 77002
USA
Phone
Undisclosed
Website
Email Address
Overview
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Truex
Browse more venture capital transactions:
Prev: 11/13/2017: NBD Nanotechnologies venture capital transaction
Next: 11/13/2017: Peloton Innovations venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs